Skip to main content
Clinical Trials/JPRN-UMIN000013476
JPRN-UMIN000013476
Not yet recruiting
未知

The effect of multimodality treatment and HPV infection in oropharyngeal squamous cell carcinoma. - Multimodality treatment and HPV in oropharyngeal cancer

The study group of basic research of the head and neck0 sites213 target enrollmentJune 1, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Oropharyngeal squamous cell carcinoma
Sponsor
The study group of basic research of the head and neck
Enrollment
213
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The study group of basic research of the head and neck

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with surgical treatment Distant metastasis Double cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Quadrivalent HPV vaccination after effective treatment of Anal Intraepithelial Neoplasia in HIV+ men (VACCAIN-P)anal intraepithelial neoplasia1004743810017987
NL-OMON44810Academisch Medisch Centrum125
Active, not recruiting
Phase 1
HPV vaccination after treatment of anal intraepithelial neoplasiaIntra-anal high-grade anal intraepithelial neoplasia (AIN) (grade 2-3) in HIV+ men that was successfully treated in the past year with conventional cauterization, cryotherapy, or other forms of local treatment.MedDRA version: 14.1 Level: LLT Classification code 10059312 Term: Anal dysplasia System Organ Class: 100000004856Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2013-002009-70-NLAcademic Medical Center125
Completed
Not Applicable
HPV Infections, Cancer of the Vulva and Therapeutical SuccessHPVHuman Papilloma Virus
NCT03082950University of Luebeck110
Completed
Not Applicable
Efficacy of quadrivalent human papillomavirus vaccine (Gardasil) for recurrent respiratoru papillomatosisrecurrent respiratory papillomatosis
JPRN-UMIN000020352Kanazawa University5
Active, not recruiting
Phase 1
HIPvac: a trial of vaccination and topical treatment in patients with anogenital wartsAnogenital wartsMedDRA version: 20.1 Level: PT Classification code 10059313 Term: Anogenital warts System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10018182 Term: Genital warts System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2013-002951-14-GBniversity College London503